Fingerprint
Dive into the research topics of 'Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: Evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically